The Health Care M&A Monthly: Drug Deals Dominate M&A–

Biotech And Pharma Outspend All Other Sectors Email this article to a friend     Email Editor Rarely have we seen a month in the health care merger and acquisition market where the financial results were as lopsided as May’s. Based on figures currently available, the...